Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Lukas Fiedler"'
Autor:
Diana F. Gareeva, Irina A. Lakman, Alexander A. Agapitov, Liana F. Sadikova, Paruir A. Davtian, Valeriia L. Kayumova, Guzel M. Nurtdinova, Elena A. Badykova, Magomed S. Kurbanov, Islam R. Idigov, Lukas Fiedler, Lukas-Jaroslaw Motloch, Аnna-Maria Dieplinger, Venera M. Timiryanova, Naufal Sh. Zagudullin
Publikováno v:
Терапевтический архив, Vol 96, Iss 1, Pp 29-35 (2024)
Background. During the pandemic of coronavirus infection (COVID-19) caused by a virus SARS-CoV-2 there has been significant variability in symptoms of the disease over time, severity of the course and in particular hospital mortality. Several SARS-Co
Externí odkaz:
https://doaj.org/article/5eb5a375d5b647a1b08212254dd08e2c
Autor:
Zemfira Khamidullina, Diana Avzaletdinova, Diana Gareeva, Tatyana Morugova, Irina Lakman, Kristen Kopp, Lukas Fiedler, Lukas J. Motloch, Naufal Zagidullin
Publikováno v:
Biomedicines, Vol 12, Iss 2, p 467 (2024)
With the onset of the coronavirus pandemic, it has become clear that patients with diabetes are at risk for more severe and fatal COVID-19. Type 2 diabetes mellitus (T2D) is a major risk factor for adverse COVID-19 outcomes. The goal of study was to
Externí odkaz:
https://doaj.org/article/93c4c5d2727643acaaf45d3946ea7d2a
Autor:
Lukas Fiedler, Lukas J. Motloch, Anna-Maria Dieplinger, Peter Jirak, Paruir Davtyan, Diana Gareeva, Elena Badykova, Marat Badykov, Irina Lakman, Aleksandr Agapitov, Liana Sadikova, Valentin Pavlov, Fabian Föttinger, Moritz Mirna, Kristen Kopp, Uta C. Hoppe, Rudin Pistulli, Benzhi Cai, Baofeng Yang, Naufal Zagidullin
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: While acute Coronavirus disease 2019 (COVID-19) affects the cardiovascular (CV) system according to recent data, an increased CV risk has been reported also during long-term follow-up (FU). In addition to other CV pathologies in COVID-1
Externí odkaz:
https://doaj.org/article/5e2dcd583bcc4eb4b30434008f09491a
Autor:
Elke Boxhammer, Meriem Bellamine, Istvan Szendey, Mike Foresti, Marc Bonsels, Joseph Kletzer, Peter Jirak, Albert Topf, Johannes Kraus, Lukas Fiedler, Anna-Maria Dieplinger, Uta C. Hoppe, Bernhard Strohmer, Lars Eckardt, Rudin Pistulli, Lukas J. Motloch, Robert Larbig
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionWhile in the CASTLE-AF trial, in patients with atrial fibrillation and heart failure with reduced ejection fraction, interventional therapy using pulmonary vein isolation was associated with outcome improvement, data on cavotricuspid isth
Externí odkaz:
https://doaj.org/article/e7c1f4a8bec74a46864e783660c1dc2f
Autor:
Ursula Rohrer, Martin Manninger, Lukas Fiedler, Clemens Steinwender, Ronald K. Binder, Markus Stühlinger, Birgit Zirngast, David Zweiker, Andreas Zirlik, Daniel Scherr
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 15, p 5029 (2023)
Background: After acute myocardial infarction (AMI), patients are at risk of sudden cardiac death. The VEST trial failed to show a reduction in arrhythmic mortality in AMI patients with an LVEF ≤ 35% prescribed with a WCD, having a lower-than-expec
Externí odkaz:
https://doaj.org/article/8211a92a42fc41529f6107a119154b20
Autor:
Lukas J. Motloch, Peter Jirak, Moritz Mirna, Lukas Fiedler, Paruir A. Davtyan, Irina A. Lakman, Diana F. Gareeva, Anton V. Tyurin, Ruslan M. Gumerov, Simon T. Matskeplishvili, Valentin N. Pavlov, Benzhi Cai, Kristen Kopp, Albert Topf, Uta C. Hoppe, Rudin Pistulli, Naufal S. Zagidullin
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
IntroductionCardiovascular events are common in COVID-19. While the use of anticoagulation during hospitalization has been established in current guidelines, recommendations regarding antithrombotic therapy in the post-discharge period are conflictin
Externí odkaz:
https://doaj.org/article/df0ac22d833b4b75bb342820539b4344
Autor:
Lukas J. Motloch, Peter Jirak, Diana Gareeva, Paruir Davtyan, Ruslan Gumerov, Irina Lakman, Aleksandr Tataurov, Rustem Zulkarneev, Ildar Kabirov, Benzhi Cai, Bairas Valeev, Valentin Pavlov, Kristen Kopp, Uta C. Hoppe, Michael Lichtenauer, Lukas Fiedler, Rudin Pistulli, Naufal Zagidullin
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
AimsWhile COVID-19 affects the cardiovascular system, the potential clinical impact of cardiovascular biomarkers on predicting outcomes in COVID-19 patients is still unknown. Therefore, to investigate this issue we analyzed the prognostic potential o
Externí odkaz:
https://doaj.org/article/8e990f1e7787410caa554f9c85be0aca
Autor:
Bernhard Ohnewein, Zornitsa Shomanova, Vera Paar, Albert Topf, Peter Jirak, Lukas Fiedler, Christina Granitz, Vincent Van Almsick, Dilvin Semo, Naufal Zagidullin, Anna-Maria Dieplinger, Juergen Sindermann, Holger Reinecke, Uta C. Hoppe, Rudin Pistulli, Lukas J. Motloch
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 9, p 3083 (2023)
(1) Background: Heart failure with reduced ejection fraction (HFrEF) remains a major health burden. Angiotensin-Receptor-Neprilysin-Inhibitors (ARNIs) are an established HFrEF therapy which increases natriuretic peptide levels by inhibiting neprilysi
Externí odkaz:
https://doaj.org/article/eef304b624da441782d11491e2b915d3
Autor:
Lukas Fiedler, Lukas J. Motloch, Peter Jirak, Ruslan Gumerov, Paruir Davtyan, Diana Gareeva, Irina Lakman, Alexandr Tataurov, Gulnaz Lasinova, Valentin Pavlov, Laurenz Hauptmann, Kristen Kopp, Uta C. Hoppe, Michael Lichtenauer, Rudin Pistulli, Anna-Maria Dieplinger, Naufal Zagidullin
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2889 (2022)
Introduction: COVID-19 survivors reveal an increased long-term risk for cardiovascular disease. Biomarkers like troponins and sST-2 improve stratification of cardiovascular risk. Nevertheless, their prognostic value for identifying long-term cardiova
Externí odkaz:
https://doaj.org/article/444015f215894f6e8dbd4d500425ac0b
Autor:
David Zweiker, Lukas Fiedler, Gabor G. Toth, Andreas Strouhal, Georg Delle-Karth, Guenter Stix, Harald Gabriel, Ronald K. Binder, Martin Rammer, Michael Pfeffer, Paul Vock, Brigitte Lileg, Clemens Steinwender, Kurt Sihorsch, Florian Hintringer, Silvana Mueller, Fabian Barbieri, Martin Martinek, Wolfgang Tkalec, Nicolas Verheyen, Klemens Ablasser, Andreas Zirlik, Daniel Scherr
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 21, p 6548 (2022)
Background: As a preventive procedure, minimizing periprocedural risk is crucially important during left atrial appendage closure (LAAC). Methods: We included consecutive patients receiving LAAC at nine centres and assessed the relationship between b
Externí odkaz:
https://doaj.org/article/2860edd92dc444fd9aa660c04ccdc386